title: Polyostotic fibrous dysplasia with contrasting responses to calcitonin and mithramycin: aetiological and therapeutic implications.
authors.forename: A
authors.initials: A
authors.lastname: Long
authors.forename: T
authors.initials: T
authors.lastname: Loughlin
authors.forename: R P
authors.initials: RP
authors.lastname: Towers
authors.forename: T J
authors.initials: TJ
authors.lastname: McKenna
mesh_terms: D000293:Adolescent; D000469:Alkaline Phosphatase / Q000097:blood; D002116:Calcitonin / Q000627:therapeutic use*; D002118:Calcium / Q000652:urine; D005357:Fibrous Dysplasia of Bone / Q000188:drug therapy*; D005359:Fibrous Dysplasia, Polyostotic / Q000188:drug therapy* / Q000201:enzymology; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D008297:Male; D010010:Osteoclasts / Q000187:drug effects; D008926:Plicamycin / Q000627:therapeutic use*
chemical_list: D002116:Calcitonin; D000469:Alkaline Phosphatase; D008926:Plicamycin; D006909:Hydroxyproline; D002118:Calcium